ProPhase Labs: Up on plans to acquire CLIA certified labs for COVID-19 testing
** Shares of drug manufacturing co PRPH.O rise 19% to $4
premarket
** Late on Wednesday, co said it plans to explore
acquisition of one or more CLIA accredited labs for COVID-19 and
other testing urn:newsml:reuters.com:*:nGNX6nvdXJ
** Co says it has entered into consulting agreement with
Predictive Technology Group Inc's PRED.PK unit Predictive
Laboratories to assist with process
** Clinical Laboratory Improvement Amendments (CLIA)
regulations establish quality standards for laboratory testing
** Up to Wednesday's close, PRPH had risen ~76% YTD
(Reporting by Dania Nadeem in Bengaluru)
((Dania.Nadeem@thomsonreuters.com))